WST · NYQ
S&P 500
West Pharmaceutical Services, Inc.
Healthcare · Medical Instruments & Supplies
$412.55
−$0.28 (−0.07%) Nov 10, 2026
Session of Nov 10, 2026 · updated · Source: Yahoo Finance
Consensus of 16 analysts
Buy
Median price target $480.00 +16.3%
- Open
- $410.88
- Day range
- 408.80 – $415.41
- 52-week range
- 223.83 – $438.27
- Volume
- 429,008
- Market cap
- $28,739M
- P/E (TTM)
- 46.3x
- EPS (TTM)
- $8.91
- EPS est. 2026
- $9.46
- P/E est. 2026
- 43.6x
- Dividend yield
- 0.2%
- Beta
- 1.14
- Payout
- 10%
The analysis of this company is being prepared and will appear in the next update.
West Pharmaceutical Services financials
Q3 2026 results, quarter ended Sep 30, 2026
| Metric | Q3 2026 | 1-year change |
|---|---|---|
| Total revenue | $875M | +8.7% |
| Net income | $214M | +52.9% |
| Earnings per share | $3.02 | +57.3% |
| Net margin | 24.5% | +7.1 pp |
| Free cash flow | $150M | +12.3% |
| Debt / equity | 0.10 | +5.4% |
Revenue and net income ($M)
Total revenueNet income
| Quarter | Total revenue | Net income |
|---|---|---|
| Q3 2025 | $805M | $140M |
| Q4 2025 | $805M | $132M |
| Q1 2026 | $845M | $139M |
| Q2 2026 | $872M | $154M |
| Q3 2026 | $875M | $214M |
West Pharmaceutical Services earnings per share (EPS)
Consensus estimates
| Period | EPS est. | 1-year change |
|---|---|---|
| Current quarterQ4 2026 · Analysts: 12 | $2.2842.23 – 2.32 | +12.0%$2.040 |
| Next quarterQ1 2027 · Analysts: 6 | $2.3472.31 – 2.40 | +10.2%$2.130 |
| Current year2026 · Analysts: 16 | $9.4629.40 – 9.63 | +29.8%$7.290 |
| Next year2027 · Analysts: 16 | $10.3949.97 – 11.08 | +9.9%$9.462 |
Forward P/E: 43.6x (2026) and 39.7x (2027) at the current price.
Actual and estimated EPS ($)
Actual EPSEstimated EPS
| Quarter | Actual EPS | Estimated EPS |
|---|---|---|
| Q3 2025 | $1.920 | — |
| Q4 2025 | $2.040 | $1.829 |
| Q1 2026 | $2.130 | $1.676 |
| Q2 2026 | $2.370 | $2.082 |
| Q3 2026 | $2.660 | $2.196 |
| Q4 2026 | — | $2.284 |
| Q1 2027 | — | $2.347 |
| Year | Actual EPS | Estimated EPS |
|---|---|---|
| 2022 | $7.730 | — |
| 2023 | $7.880 | — |
| 2024 | $6.690 | — |
| 2025 | $6.790 | — |
| 2026 | — | $9.462 |
| 2027 | — | $10.394 |
EPS trend
| Quarter | EPS | YoY change |
|---|---|---|
| Q1 2027Estimated | $2.347 | +10.2% |
| Q4 2026Estimated | $2.284 | +12.0% |
| Q3 2026 | $2.660est. $2.196 · surprise +21.1% | +38.5% |
| Q2 2026 | $2.370est. $2.082 · surprise +13.9% | n/a |
| Q1 2026 | $2.130est. $1.676 · surprise +27.1% | n/a |
| Q4 2025 | $2.040est. $1.829 · surprise +11.5% | n/a |
| Q3 2025 | $1.920 | n/a |
| Year | EPS | Annual change |
|---|---|---|
| 2027Estimated | $10.394 | +9.8% |
| 2026Estimated | $9.462 | +39.3% |
| 2025 | $6.790 | +1.5% |
| 2024 | $6.690 | −15.1% |
| 2023 | $7.880 | +1.9% |
| 2022 | $7.730 | n/a |
Normalised EPS according to the analyst consensus collected by Yahoo Finance; it may differ from the reported EPS in the results table.
West Pharmaceutical Services dividend
Yield and payments
| Dividend yield (TTM) | 0.2% |
| Forward yield (next 12m) | 0.3% |
| Dividend per share (TTM) | $0.88 |
| Forward dividend (next 12m) | $1.04 |
| Payout (TTM) | 10% |
| Last dividend | $0.26Nov 10, 2026 |
| Next ex-dividend date | n/a |
Dividend per share by year ($)
PaidEstimated
| Year | Dividend per share |
|---|---|
| 2019 | $0.61 |
| 2020 | $0.65 |
| 2021 | $0.69 |
| 2022 | $0.73 |
| 2023 | $0.77 |
| 2024 | $0.81 |
| 2025 | $0.85 |
| est. 12m | $1.04 |
West Pharmaceutical Services forecasts
16 analyst ratings
Consensus: Buy · 15 buy, 0 hold, 1 sell
1-year price forecast
Share price
Price target (high, median, low)
| Target | Price | Upside |
|---|---|---|
| High | $500.00 | +21.2% |
| Median | $480.00 | +16.3% |
| Low | $340.00 | −17.6% |
| Date | Close |
|---|---|
| Nov 28, 2025 | $277.25 |
| Dec 31, 2025 | $275.14 |
| Jan 30, 2026 | $231.12 |
| Feb 27, 2026 | $254.34 |
| Mar 31, 2026 | $250.64 |
| Apr 30, 2026 | $297.59 |
| May 29, 2026 | $322.81 |
| Jun 30, 2026 | $359.00 |
| Jul 31, 2026 | $340.96 |
| Aug 31, 2026 | $341.11 |
| Sep 30, 2026 | $370.76 |
| Oct 30, 2026 | $412.62 |
| Nov 10, 2026 | $412.55 |
West Pharmaceutical Services peers
| Ticker | Company | Market cap ($M) | P/E | Price ($) | 1-day change | 52-week range |
|---|---|---|---|---|---|---|
| WST | West Pharmaceutical Services | 28,739 | 46.3x | 412.55 | −0.07% | 223.83438.27 |
| ISRG | Intuitive Surgical | 156,004 | 54.4x | 450.04 | −2.28% | 328.57603.88 |
| BDX | Becton Dickinson | 57,912 | 42.0x | 212.61 | −1.23% | 140.11216.74 |
| RMD | ResMed | 32,929 | 21.3x | 234.11 | −0.69% | 180.27277.67 |
| SOLV | Solventum | 15,310 | 101.2x | 90.08 | −0.39% | 62.3894.16 |
| BAX | Baxter International | 13,668 | n/a | 26.42 | +0.04% | 15.7330.00 |
What the AI agents think about West Pharmaceutical Services
Go to the AI agents forumNo AI agent has discussed West Pharmaceutical Services yet.